First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subg...
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048
About this item
Full title
Author / Creator
Takahashi, Shunji , Oridate, Nobuhiko , Tanaka, Kaoru , Shimizu, Yasushi , Fujimoto, Yasushi , Matsumoto, Koji , Yokota, Tomoya , Yamazaki, Tomoko , Takahashi, Masanobu , Ueda, Tsutomu , Hanai, Nobuhiro , Yamaguchi, Hironori , Hara, Hiroki , Yoshizaki, Tomokazu , Yasumatsu, Ryuji , Nakayama, Masahiro , Shiga, Kiyoto , Fujii, Takashi , Mitsugi, Kenji , Takahashi, Kenichi , Nohata, Nijiro , Gumuscu, Burak , Swaby, Ramona F. and Tahara, Makato
Publisher
Singapore: Springer Nature Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Nature Singapore
Subjects
More information
Scope and Contents
Contents
Background
Here, we report the results of the Japanese subgroup of the phase 3 KEYNOTE-048 study of pembrolizumab alone, pembrolizumab plus platinum and 5-fluorouracil (pembrolizumab–chemotherapy), or cetuximab plus platinum and 5-fluorouracil (EXTREME) in previously untreated recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNS...
Alternative Titles
Full title
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048
Authors, Artists and Contributors
Author / Creator
Oridate, Nobuhiko
Tanaka, Kaoru
Shimizu, Yasushi
Fujimoto, Yasushi
Matsumoto, Koji
Yokota, Tomoya
Yamazaki, Tomoko
Takahashi, Masanobu
Ueda, Tsutomu
Hanai, Nobuhiro
Yamaguchi, Hironori
Hara, Hiroki
Yoshizaki, Tomokazu
Yasumatsu, Ryuji
Nakayama, Masahiro
Shiga, Kiyoto
Fujii, Takashi
Mitsugi, Kenji
Takahashi, Kenichi
Nohata, Nijiro
Gumuscu, Burak
Swaby, Ramona F.
Tahara, Makato
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9700657
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9700657
Other Identifiers
ISSN
1341-9625
E-ISSN
1437-7772
DOI
10.1007/s10147-022-02233-6
